Barinthus Biotherapeutics plc (BRNS)

NASDAQ: BRNS · IEX Real-Time Price · USD
2.380
+0.030 (1.28%)
At close: Mar 28, 2024, 3:59 PM
2.300
-0.080 (-3.36%)
After-hours: Mar 28, 2024, 4:06 PM EDT

Total Valuation

BRNS has a market cap or net worth of $92.63 million. The enterprise value is -$36.48 million.

Market Cap 92.63M
Enterprise Value -36.48M

Important Dates

The last earnings date was Wednesday, March 20, 2024, before market open.

Earnings Date Mar 20, 2024
Ex-Dividend Date n/a

Share Statistics

BRNS has 38.64 million shares outstanding.

Shares Outstanding 38.64M
Owned by Insiders (%) 3.69%
Owned by Institutions (%) 47.85%
Float 18.24M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 115.50
Forward PS 68.11
PB Ratio 0.50
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.46, with a Debt / Equity ratio of 0.07.

Current Ratio 12.46
Quick Ratio n/a
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2,728.36

Financial Efficiency

Return on equity (ROE) is -35.20% and return on invested capital (ROIC) is -42.01%.

Return on Equity (ROE) -35.20%
Return on Assets (ROA) -30.80%
Return on Capital (ROIC) -42.01%
Revenue Per Employee $7,495
Profits Per Employee -$685,486
Employee Count 107
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax -3.08M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +6.73% in the last 52 weeks. The beta is -0.48, so BRNS's price volatility has been lower than the market average.

Beta (1Y) -0.48
52-Week Price Change +6.73%
50-Day Moving Average 2.68
200-Day Moving Average 2.75
Relative Strength Index (RSI) 39.38
Average Volume (30 Days) 14,777

Short Selling Information

Short Interest 11,890
Short Previous Month 12,286
Short % of Shares Out 0.05%
Short % of Float n/a
Short Ratio (days to cover) 0.58

Income Statement

In the last 12 months, BRNS had revenue of $802,000 and -$73.35 million in losses. Loss per share was -$1.91.

Revenue 802,000
Gross Profit 802,000
Operating Income -83.91M
Pretax Income -76.42M
Net Income -73.35M
EBITDA -69.64M
EBIT -76.39M
Loss Per Share -$1.91
Full Income Statement

Balance Sheet

The company has $142.09 million in cash and $12.98 million in debt, giving a net cash position of $129.11 million or $3.34 per share.

Cash & Cash Equivalents 142.09M
Total Debt 12.98M
Net Cash 129.11M
Net Cash Per Share $3.34
Equity / Book Value 186.78M
Book Value Per Share 4.83
Working Capital 144.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$50.93 million and capital expenditures -$5.41 million, giving a free cash flow of -$56.34 million.

Operating Cash Flow -50.93M
Capital Expenditures -5.41M
Free Cash Flow -56.34M
FCF Per Share -$1.47
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -10,463.09% and -9,145.51%.

Gross Margin 100.00%
Operating Margin -10,463.09%
Pretax Margin -9,528.93%
Profit Margin -9,145.51%
EBITDA Margin -8,682.92%
EBIT Margin -9,525.44%
FCF Margin -7,024.69%

Dividends & Yields

BRNS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.57%
Shareholder Yield -0.57%
Earnings Yield -79.18%
FCF Yield -60.82%

Analyst Forecast

The average price target for BRNS is $8.00, which is 236.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.00
Price Target Difference 236.13%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) 12.69%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BRNS has an Altman Z-Score of 0.5 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.5
Piotroski F-Score 1